The First Crispr Medicine Is Now Approved in the US

The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.

Related Keywords

United States ,United Kingdom ,Boston ,Massachusetts ,Vence Bonham ,Samarth Kulkarni ,National Institutes Of Health ,Vertex Pharmaceuticals Of Boston ,National Human Genome Research Institute ,Drug Administration ,Vertex Pharmaceuticals ,Crispr Therapeutics ,National Institutes ,Biotech ,Crispr Cas9 ,Gene Editing ,Genetic Engineering ,Diseases ,